You have read all your free articles, to continue reading subscribe to read the rest of this content.
TFS International has announced an agreement with the Pharma Intelligence division of Informa for their global research and development (R&D) platform - Citeline. “At TFS we are already proud of the strategic and operational services that we provide our biotechnology and pharma clients.”Already a subscriber Login You have read all…
The European Medicines Agency Committee for Orphan Medicinal Products (COMP) has issued a positive opinion on the company’s application for orphan designation status for its Phase II clinical candidate, ilixadencel, for the treatment of Gastrointestinal Stromal Tumors (GIST). The COMP opinion wAlready a subscriber Login You have read all your…
AstraZeneca and MSD have announced that the European Commission (EC) and the Japanese Ministry of Health, Labour and Welfare have approved Lynparza (olaparib) as a 1st-line maintenance treatment for women with BRCA-mutated advanced ovarian cancer. The licensed indication is as a maintenance trAlready a subscriber Login You have read all your…
Novo Nordisk has reached a resolution with the US federal government and the states about an investigation launched in February 2011 concerning sales and marketing practices for Victoza, a medicine to treat type 2 diabetes. The investigation was disclosed by Novo Nordisk for the first time in a cAlready a…
